| Date | Title | Description |
| 21.05.2024 | Oxford Endovascular – raises £8m to tackle brain aneurysms | Delighted to announce our latest investment in Oxford Endovascular, a spin-out from Oxford University, working to prevent brain haemorrhage by treating brain aneurysms, a condition that affects 1 in 50 persons. The investment was featured i... |
| 07.05.2024 | Parkwalk – EIS explained: what is the Enterprise Investment Scheme?
Conclusion | The Enterprise Investment Scheme (EIS) is a useful tax planning tool for investors to take advantage of 5 generous tax benefits*, as well as investing in some of the brightest minds and world-changing innovations in the UK. Our CEO, Moray W... |
| 07.05.2024 | Parkwalk Portfolio Showcase 2024 | On Wednesday, 1st May 2024, we held our annual Parkwalk Portfolio Showcase at the Royal Society of Chemistry. The showcase highlighted some of the world-changing innovations we have invested in, which have all benefited from funding from th... |
| 07.05.2024 | Parkwalk – Investing in EIS before Tax Year End | As we approach Tax Year end, there has never been a more compelling time to understand the value of the Enterprise Investment Scheme (EIS). Our CEO, Moray Wright, and Professional Adviser, sheds light on how EIS is making a significant impa... |
| 14.03.2024 | Parkwalk – ‘Founders at the University of Cambridge’ announces first cohort for Start Accelerator programme | From waste plastic transformation to a smart fitness device for the brain, the Founders at the University of Cambridge Start 1.0 accelerator has announced 11 start-ups selected for the programme. As an Investment Partner, we are delighted t... |
| 08.03.2024 | Parkwalk x IP Group – International Women’s Day 2024 panel | On the 6th of March 2024, Parkwalk and IP Group’s Women’s Networking Group hosted a panel discussion at their offices to celebrate International Women’s Day (IWD), with the IWD 2024 theme of ‘inspire inclusion’, and the next generation of f... |
| 08.03.2024 | Parkwalk – John Pearson appointed Chief Investment Officer | After fifteen years at the helm of Parkwalk, Alastair Kilgour has decided to step back from being Chief Investment Officer with effect from the end of December 2023.
He will, of course, remain a Founder of Parkwalk and will spend several mo... |
| 28.02.2024 | Parkwalk – Moray Wright, CEO, speaks to IFA Magazine | In a recent interview with IFA/GBI magazine, Parkwalk CEO Moray Wright discusses the most significant growth opportunities for investment, the most common risks for investors and explains Parkwalk’s investment strategy.
Read the full interv... |
| 26.02.2024 | adsilico – raises £3.5m funding round | Delighted to announce our investment into adsilico as part of a £3.5m seed funding round, as seen in The Times today. The University of Leeds spin-out is a ground-breaking computational medicine company, developing an end-to-end in-silico t... |
| 21.02.2024 | Echopoint Medical – raises £4.2m in series A funding round | Thrilled to announce our latest investment into Echopoint Medical as part of a £4.2m series A funding round. The University College London spin-out has designed an advanced diagnostic solution for cardiovascular care to improve patient outc... |
| 24.01.2024 | Wayland Additive – raises £4.2m in latest funding round | Thrilled to announce our latest investment into Wayland Additive as part of a £4.2m funding round. Wayland is a Huddersfield-based company providing electron beam, 3D printing technology using Calibur3 metal additive manufacturing (AM) mach... |
| 24.01.2024 | Parkwalk – Imperial College Enterprise Fund III launch |
We are delighted to announce the launch of our Imperial College Enterprise Fund (ICEF) III. The Fund is managed by Parkwalk in conjunction with Imperial Enterprise. The Fund invests in early-stage hard science and disruptive technology com... |
| 24.11.2023 | Parkwalk – ‘Best EIS Investment Manager’ at the Growth Investor Awards 2023 | Parkwalk are thrilled to have won ‘Best EIS Investment Manager’ at the Growth Investor Awards 2023, for the second year running. The judges recognised our returns to our investors and our unique strategy investing into cutting-edge technolo... |
| 21.11.2023 | Parkwalk supports ‘Founders at the University of Cambridge’ pre-seed accelerator | Along with 100 experts from Graphcore, Arm, Google and Stripe, we are proud to support the Founders at the University of Cambridge, with Cambridge Enterprise, aiding the next generation of start-ups. This new initiative is the first pre-see... |
| 12.11.2023 | Parkwalk – launches Knowledge Intensive EIS Fund III | We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund III, an HMRC-approved EIS Fund. As featured in Investment Week, the third Knowledge Intensive Fund will back cutting-edge technology companies spun out of le... |
| 04.11.2023 | Parkwalk – University of Oxford Innovation Fund VI is now closed | We are delighted to announce that our University of Oxford Innovation Fund VI is now closed, surpassing its target and raising £3m. As featured in an article by UKTN, the Fund is run in conjunction with Oxford University Innovation, backing... |
| 27.10.2023 | Parkwalk – Acquisition of PetMedix | Parkwalk are delighted to announce the acquisition of our portfolio company PetMedix, generating a positive return for our EIS investors. |
| 27.10.2023 | Mogrify – extends Series A financing to $46m USD | Parkwalk is pleased to announce that portfolio company, Mogrify, have extended their Series A financing to $46m USD. The University of Cambridge and University of Bristol spinout is enabling the next generation of gene sequencing and gene-r... |
| 27.10.2023 | Phasecraft – raises £13m in Series A Funding Round | We are delighted to announce our latest investment into Phasecraft as part of a £13m Series A Funding Round. The University College London spin-out designs quantum software for quantum information processors encompassing both near-term inte... |
| 27.10.2023 | Parkwalk – 2023 Beauhurst report on university spinouts | Parkwalk have launched our annual ‘Equity Investments into Spinouts’ 2023 report, in conjunction with Beauhurst. The report findings also feature in the Financial Times, “Investment in UK university spinouts falls after decade of growth“ ar... |
| 18.08.2023 | Entia – raises $20m in Series A funding round | Parkwalk is thrilled to announce our latest investment into Entia as part of a $20m series A funding round to launch the world’s most comprehensive monitoring solution for patients undergoing cancer therapy. |
| 27.06.2023 | Parkwalk – University of Oxford Innovation Fund VI launch | We are delighted to announce the launch of our University of Oxford Innovation Fund (UOIF) VI. The fund is managed by Parkwalk, in conjunction with the University of Oxford’s Technology Transfer Office, Oxford University Innovation. The Fun... |
| 08.06.2023 | Parkwalk – Portfolio Showcase 2023 | On Wednesday 7th June 2023, we held our annual Portfolio Showcase at the Royal Society of Chemistry, showcasing innovative companies from our portfolio. |
| 03.06.2023 | OXA – Oxbotica unveils a new brand, as the company scales globally | Parkwalk is delighted to announce Oxbotica’s rebranding to Oxa, marking the next stage in the company’s growth as it prepares to scale in North America and Europe. Oxa has developed autonomous vehicle software that operates anywhere without... |
| 11.05.2023 | AccelerComm – raises £21.5m in Series B Funding Round | Parkwalk announces our recent funding round into new portfolio company AccelerComm. The University of Southampton spin-out has developed patented communication algorithms for 5G, doubling network capacity whilst halving power consumption an... |
| 02.05.2023 | Paragraf – Acquires Cardea Bio, Extending Graphene Electronics Industry Leadership | Parkwalk is delighted to announce that, in a first for the graphene electronics industry, leading integrated device manufacturer Paragraf is acquiring graphene biosensor market pioneer Cardea Bio to accelerate the mass production of a new g... |
| 28.04.2023 | Wayland Additive – raises £4.6m in latest funding round | We are delighted to announce our latest investment into Wayland Additive, as part of a £4.6m funding round. This latest investment will increase Wayland’s in-house production capability delivering more machines and materials to its customer... |
| 30.03.2023 | Parkwalk – Investing in the Science and Technology of Tomorrow | Thrilled to see our CEO, Moray Wright, featured in Business Weekly’s article, discussing technology funding and the UK’s economic ecosystems, especially pension funds. The government’s aim to develop the UK into a science superpower is focu... |
| 21.03.2023 | Parkwalk – Improving Healthcare by Investing in Genomics | To mark the end of Healthcare Science Week, we discuss the value and impact of investing in genomics. We also give examples of some ground-breaking genomic companies Parkwalk has invested in. |
| 14.03.2023 | Legislate raises $3.6m in latest funding round | We are thrilled to announce our recent investment in Legislate, as part of a $3.6m funding round. The University of Oxford spin-out has designed a legal SaaS platform that enables small businesses and landlords to easily create, sign, and m... |
| 09.03.2023 | Parkwalk celebrates International Women’s Day 2023: breaking down gender inequality | To celebrate International Women’s Day 2023, we wanted to recognise the amazing women who work at Parkwalk and the women founders and innovators behind some of our portfolio companies. |
| 01.03.2023 | Quantum Motion Technologies – largest funding round in UK quantum computing | We are thrilled to announce our latest investment into Quantum Motion Technologies as part of a £42m funding round, the largest funding round in UK quantum computing. The University of Oxford spin-out is developing a revolutionary technolog... |
| 01.03.2023 | Parkwalk – Meet the Portfolio series | As part of our annual Portfolio Showcase in 2022, we had the opportunity to sit down with some of our portfolio companies to speak to them about their experiences. We have showcased these in our ‘Meet the Portfolio’ series of videos below.... |
| 09.02.2023 | Parkwalk – International Day of Women and Girls in Science | Parkwalk is delighted to celebrate International Day of Women and Girls in Science 2023. This year we focus on the endless opportunities STEM opens for women and girls, around the globe. |
| 12.01.2023 | Parkwalk – 2022 in numbers | 2022 was another eventful year, especially with the global economic, political and social situation. Despite the turbulence of 2022, Parkwalk has seen yet another successful and busy year. We want to take this time to wish a Happy New Year ... |
| 01.01.2023 | Parkwalk – Merry Christmas and a Happy New Year | We’d like to wish everyone a Merry Christmas and a Happy New Year from everyone at Parkwalk. |
| 23.12.2022 | Qkine – raises £4.3m in latest funding round | We’re delighted to announce our recent investment in Qkine, as part of a £4.3m funding round. The University of Cambridge spin-out has designed a proprietary refolding technology and protein purification technique to produce high quality gr... |
| 25.11.2022 | Parkwalk – ‘Best EIS Investment Manager’ at Growth Investor Awards 2022 | Parkwalk is thrilled to announce our win at the Growth Investor Awards 2022. Parkwalk was awarded ‘Best EIS Investment Manager’, recognising our deployment of capital, fundraising and returns to our investors. |
| 24.11.2022 | Diffblue – raises £8m in latest funding round | We’re thrilled to announce our latest investment into Diffblue. The University of Oxford spin-out uses AI to write unit tests that help software teams and organisations efficiently improve their code coverage and quality. The funding round ... |
| 18.11.2022 | Parkwalk – short-term politics vs. long-term investment | As the Autumn budget is right around the corner and the EIS sunset clause still set to be removed, our Investment Director Martin Glen, discusses a number of reasons why short-term politics should not impact longer term investment into rese... |
| 18.11.2022 | Cambridge GaN Devices – raises $19m in Series B Funding round | We’re delighted to announce the latest funding round for Cambridge GaN Devices, a University of Cambridge spin-out creating and developing the next generation of fabless semiconductors, using energy-efficient GaN-based power devices. This l... |
| 03.11.2022 | Investment: Enhanc3D Genomics raises £10m in Series A funding round | Parkwalk is delighted to announce an investment into Enhanc3D Genomics as part of a £10m Series A funding round. The Cambridge University spin-out has designed a platform that combines molecular biology technology with machine learning to d... |
| 09.09.2022 | Opsydia – Latest funding round | Opsydia, the diamond identifying security company, raises capital in their latest funding round. This investment will help, the Oxford University spin-out, to drive growth and enter its next phase of development. Parkwalk are delighted to b... |
| 09.09.2022 | Parkwalk – 9th UCEF Fund closing soon | After a successful fundraising period, our University of Cambridge Enterprise Fund IX (UCEF IX) is closing later in September 2022. The Fund invests in early-stage businesses spun-out of the University of Cambridge, and to date, the UCEF Fu... |
| 20.08.2022 | Flusso – Acquired for £28 million | We are delighted to announce the acquisition of portfolio company Flusso for £28m, resulting in an excellent return for our EIS investors. The flow sensors technology specialists company Flusso has been jointly acquired by an international ... |
| 19.07.2022 | Parkwalk – The UK’s leading university spinout investor, CEO features in UKTN | As the UK’s leading investor in university spinouts, Parkwalk’s CEO, Moray Wright, discusses the origins of Parkwalk, the challenges of early-stage funding, and some of the largest Parkwalk investments to date, in UKTN‘s article. |
| 19.07.2022 | Parkwalk – EIS & the Sunset Clause explained, CEO featured in FT Adviser | |
| 22.06.2022 | Parkwalk – ‘Meet the Portfolio’ showcase 2022 | On Wednesday 8th June 2022, our annual ‘Meet the Portfolio’ showcase returned to the Royal Society of Chemistry after a 2-year COVID-19-related hiatus. |
| 22.06.2022 | Psyomics – raises £2.4m in Series B round | We are delighted to announce our next investment in Psyomics as part of a £2.4m Series B funding round. The company specialises in improving the diagnosis of mental health patients by using enhanced digital questionnaires and the use of blo... |
| 02.06.2022 | MoA Technology – raises £35m in Series B round | We are thrilled to announce our next investment into MoA technology as part of a £35m Series B funding round. The plant genetics company spun-out from Oxford University has developed a range of bespoke proprietary technology to generate pot... |
| 24.05.2022 | Parkwalk – Can ESG & EIS go hand in hand? | Parkwalk’s CEO, Moray Wright, has been featured in GrowthBusiness discussing whether ‘ESG and EIS can go hand in hand’. The article outlines how, when tackling world issues, EIS funds can ensure university spinouts receive the early funding... |
| 30.04.2022 | Ceryx Medical – raises £3.8m seed round | Ceryx Medical raises £3.8m, in seed funding round to pilot their cardiac device, Cysoni, to in-human trials. Parkwalk are delighted to announce a further investment in Ceryx, developing a bioelectronic technology which can mimic nerve centr... |
| 30.04.2022 | Parkwalk – University of Cambridge Enterprise Fund IX launch | The University of Cambridge Enterprise Fund IX once again brings together Cambridge Enterprise and Parkwalk, which has now overseen over £100m of investment and completed over 50 joint investments into Cambridge-based companies, to offer an... |
| 11.04.2022 | GripAble – raises $11m Series A round | GripAble raises $11m in Series A funding to deliver data-driven neuro and musculoskeletal rehab. Parkwalk are delighted to announce a further investment in GripAble, a digital healthcare company delivering rehabilitation programmes through ... |
| 23.03.2022 | Parkwalk – Record funding for university ‘spin-outs’ in Beauhurst report 2022 | Parkwalk has been named as the top investor into spinouts for 2021, completing 31 deals, in the latest research on ‘Equity Investment into UK Spinouts’, a report carried out by Beauhurst. The report also states that UK university spin-outs ... |
| 18.03.2022 | Parkwalk – CEO joins FT Adviser podcast on EIS & VCT | Moray Wright, CEO, Parkwalk spoke to FT Adviser as part of their In Focus Podcast: ‘VCT and EIS industry has come of age’ to discuss how EIS has become increasingly popular and how it can be a useful tool in your investment portfolio. |
| 16.03.2022 | OW Smell Digital – closes £1m seed round | Parkwalk are delighted to announce an investment in innovative digital smell company OW Smell Digital. Parkwalk led the £1m seed funding round. |
| 08.03.2022 | Parkwalk – International Women’s Day 2022 interviews with portfolio leaders | To celebrate International Women’s Day 2022, we asked three of our portfolio companies with inspiring female leaders, a few questions around working in venture capital, gender equality and their achievements to date. |
| 03.03.2022 | Bonnet – electric vehicle charging platform raises £4m | Bonnet, an investment in the Imperial College Innovation Fund I, has secured $5.5 million (£4m) total investment to support in tripling the team’s headcount and securing new charge point operator partnerships. Bonnet plans to expand its cov... |
| 01.03.2022 | Paragraf – closes $60m Series B | Parkwalk are delighted to announce a further investment in graphene-based electronics technology company Paragraf. The funding round will enable the business to increase its technological capacity globally and enhance its R&D capabiliti... |
| 22.02.2022 | Semarion – closes Seed round | Parkwalk are delighted to announce an investment in Semarion, who are revolutionising in-vitro cell handling with applications across drug discovery and life sciences R&D. |
| 16.02.2022 | Parkwalk – featured in top 10 most active investors 2021 | Parkwalk have been named in the ‘top 10 most active investors’ in Beauhurst’s annual report on equity investment in the UK private markets – The Deal 2021. To download the full report click here. |
| 14.02.2022 | Bramble Energy – closes £35m round | Parkwalk are delighted to announce an investment in Bramble Energy as part of a £35m funding round, to help deploy its disruptive fuel cell stack technology to enable decarbonisation across a number of industries and sectors. |
| 10.02.2022 | Orthox – closes £9.2m Series A round | Parkwalk are delighted to announce an investment in Orthox as part of a $12.5m (£9.2m) Series A round for clinical trials of Knee Cartilage Repair FibroFix™ product platform. Parkwalk led the round, joined by existing shareholders OIC/OTIF ... |
| 29.01.2022 | Diffblue – closes Series A round | Parkwalk are delighted to announce an investment into Diffblue, who are a pioneer in using artificial intelligence to automate writing unit tests. Diffblue are a spin-out from the University of Oxford. |
| 20.01.2022 | Pathfinder Medical – raises £8.5m to transform dialysis | Parkwalk are delighted to announce an investment into Pathfinder Medical, a medical device company aiming to transform dialysis treatment with its minimally invasive, precision-guided device; originally spun-out of Imperial College London. ... |
| 20.01.2022 | Parkwalk – 2021 in Numbers | 2021 was another successful and busy year at Parkwalk. We would like to take this opportunity to wish a Happy New Year to all our investors, partners, supporters and particularly our portfolio company management teams who have done so much ... |
| 02.06.2021 | Microsaic Systems – signs OEM commercial agreement | Microsaic Systems Signs Commercial Agreement with Leading Global Scientific Company to Create New Analytical Instruments based on ‘Triple Quad’ Technology |
| 02.06.2021 | Horizon Discovery Says It Has Continued To Trade Strongly Since IPO | Horizon Discovery Group PLC said Wednesday that it had continued to trade strongly since its initial public offering. |
| - | Parkwalk – Growth Investor Awards 2021 finalist | We are delighted to share that we have been shortlisted for four awards at the Growth Investor Awards, including ‘Best EIS Investment Manager’, ‘Growth Investor of the Year’, ‘Most Impactful investment’ and ‘Best New Product or Service’.... |
| - | Parkwalk – listed as one of the most active Series A & B investors | Parkwalk have been named in the list of most active investors who led or co-led series A or B deal in Europe in Crunchbase News’s report on ‘Europe’s Most Active Startup Investors In 2021′. Funding into Europe’s startups in 2021 grew by mor... |
| - | Congenica, Mogrify and Phoremost – award winners | Congratulations to Parkwalk portfolio companies, Congenica, Mogrify and Phoremost, who all won awards at the 2019 Cambridge Independent Science Technology Awards last night. The full list of winners can be found here |
| - | Xeros: Positive update on contracts | Xeros Technology Group plc (AIM: XSG), the innovative developer of a patented polymer bead laundry cleaning system with multiple identified commercial applications, is pleased to announce that, following its latest cleaning system contract ... |
| - | PetMedix – closes $37m Series B round | Parkwalk are pleased to announce an investment in PetMedix a Cambridge University spin out, leading the way in antibody innovation in animal health. Parkwalk co-led the $37m Series B funding round with Digitalis Ventures. |
| - | PervasID – University of Cambridge Enterprise Fund IV investment | We are delighted to announce that the University of Cambridge Enterprise Fund IV, managed by Parkwalk, has invested in PervasID, a spin-out from the Department of Engineering. |
| - | Ditto AI – Parkwalk closes investment | Ditto AI Ltd, the UK-based Artificial Intelligence company, is pleased to announce that it has raised £4m in equity funding. The round was completed by a consortium of private and institutional investors including IP Group plc. |
| - | Perpetuum – Parkwalk closes follow on investment | We have recently closed a follow-on investment in Perpetuum for the Opportunities EIS Fund, alongside existing investors IP Group and ETF. |
| - | OxfordPV | Parkwalk closes OxfordPV follow-on investment |
| - | Ceres Power – Miura to Launch New CHP Fuel Cell | Miura Co., Ltd. is pleased to announce the market launch of a new fuel cell system (FC-5B) in October 2019. |
| - | Fund Managers Comments | EU Approves increased EIS tax breaks |
| - | Clean Air Power | Major Order for Genesis-EDGE Dual-FuelTM Product |
| - | OxfordPV – closes further funding round | We are pleased to announce that Parkwalk has made a further investment in OxfordPV through a Parkwalk Syndicate. |
| - | ACAL Energy | FT: UK seeks to keep lead in fuel cells |
| - | RoadMap – University of Cambridge Enterprise Fund III investment | We have recently made an investment in RoadMap for the University of Cambridge Enterprise Fund III in a Series ‘A’ financing. |
| - | Microsaic | Microsaic – new video of the 4000 MiD, the world’s smallest single quadrupole mass spectrometer:
View video here |
| - | Reinnervate | Reinnervate: Launches Novel Platform for the Propagation of Stem Cells |
| - | Kalium Health – secures investment | Kalium Health, which aims to transform the lives of patients with kidney disease, today announces the completion of a seed investment round. Cambridge Enterprise led the over-subscribed round with participation from Kidney Research UK, Camb... |
| - | Entia – raises $12m funding & Pfizer partnership | Parkwalk are pleased to announce an investment in Entia, an Imperial College London spin out, who have developed a virtual oncology platform, which allows patients to perform their own blood tests and enables healthcare teams to remotely mo... |
| - | Youku Tudou Announces Collaboration With Mirriad to Offer High-Tech ‘Native in-Video’ Ads | – Samsung becomes the first brand to jump onboard |
| - | Phasecraft – Parkwalk investment | Parkwalk are delighted to welcome Phasecraft to its portfolio following an investment from the Parkwalk Opportunities EIS Fund. |
| - | Xeros – scoops major awards on both sides of the Atlantic | Ground-Breaking Commercial Laundry System Wins a Prestigious Edison Award in the USA and Is Named University Spin-Out of the Year at the UK New Energy & Cleantech Awards: |
| - | Arkivum and UKCloud announce partnership for public sector archiving | 28 Feb 2017 |
| - | Clean Air Power | Positive trading update |
| - | Cambridge Touch Technologies – follow-on investment | We have recently made a follow-on investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund IV, the Parkwalk UK Tech Fund VII and the Parkwalk Opportunities Fund in a series ‘A’ financing round. |
| - | Bodle Technologies – Parkwalk closes University of Oxford Isis Fund investment | We are delighted to announce that the University of Oxford Isis Fund II has completed an investment in Bodle Technologies Limited, who have developed a novel, smart material for use in low-energy high-resolution displays and glazing. Bodle’... |
| - | Horizon Discovery | Horizon Discovery: License Agreement agreed for Zinc Finger Nuclease Gene Editing Technology |
| - | Lettus Grow – University of Bristol Enterprise Fund II investment | We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Lettus Grow. |
| - | Ilika plc – Toyota Research Institute brings artificial intelligence to the hunt for new materials with Ilika | Ilika (AIM: IKA), a pioneer in materials innovation and solid-state battery technology, announces that Toyota Research Institute (TRI) has released further information relating to the collaboration Ilika announced on 9th March 2017. |
| - | Parkwalk closes Mirriad investment | We are pleased to announce that Parkwalk have closed an investment into Mirriad, the leading provider of NIVA (Native In-Video Advertising) services to brands and agencies looking to address the growing challenges presented by ad skipping a... |
| - | Arkivum – Jersey Heritage contract | Jersey Heritage has chosen Arkivum Perpetua to store and preserve the huge volumes of digital records in its care. Holding the complete public record of States of Jersey, a photo archive of around 1.5 million images and digitised artefacts ... |
